First-trimester screening for Down's syndrome in in vitro fertilization pregnancies [4]

Fertility and Sterility

Volumn 76, Issue 6, 2001, Pages 1282-1283

  Niemimaa, Marko ^a   Heinonen, Seppo ^b   Seppälä, Maija ^c   Hippeläinen, Marita ^b   Martikainen, Hannu ^a   Ryynänen, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Department of Obstetrics and Gynecology ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GEOMETRY; GESTATIONAL AGE; HUMAN; LABORATORY DIAGNOSIS; LETTER; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MULTICENTER STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRISOMY 21;

EID: 0035199036     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)02871-0     Document Type: Article

References (6)

1. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening
2. Maternal serum screening for fetal Down syndrome in IVF pregnancies
3. Serum markers for Down's syndrome in women who have had in vitro fertilisation: Implications for antenatal screening
4. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A
5. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
6. Evaluation of first trimester maternal screening for Down's syndrome in Eastern and Northern Finland